U.S. FDA Approved Drugs from 2015–June 2020: A Perspective-Reference-Cited by-同舟云学术

U.S. FDA Approved Drugs from 2015–June 2020: A Perspective

Published:2021-02-22 Issue:5 Volume:64 Page:2339-2381
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Bhutani Priyadeep¹²,Joshi Gaurav³^ORCID,Raja Nivethitha¹,Bachhav Namrata⁴,Rajanna Prabhakar K.¹^ORCID,Bhutani Hemant⁵^ORCID,Paul Atish T.²,Kumar Raj³^ORCID

Affiliation:

1. Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Centre, Syngene International Limited, Bangalore 560099, India

2. Department of Pharmacy, Birla Institute of Technology and Science (BITS) Pilani, Pilani Campus, Rajasthan 333031, India

3. Laboratory for Drug Design and Synthesis, Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Bathinda 151001, India

4. 1015 E Cozza Drive # 12, Spokane Washington 99208, United States

5. Pharmaceutical Development, Biocon Bristol-Myers Squibb R&D Centre, Bristol-Myers Squibb India Private Limited, Bangalore 560099, India

Funder

Department of Science and Technology, Ministry of Science and Technology

Bristol-Myers Squibb

Syngene International Limited

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c01786